DekaBank Deutsche Girozentrale’s Arcus Biosciences RCUS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$396K	–	1306
2025 Q4	$396K	Hold	20,000	–	–	﹤0.01%	1041
2025 Q3	$392K	Hold	20,000	–	–	﹤0.01%	1029
2025 Q2	$395K	Hold	20,000	–	–	﹤0.01%	1021
2025 Q1	$365K	Hold	20,000	–	–	﹤0.01%	1014
2024 Q4	$345K	Hold	20,000	–	–	﹤0.01%	1063
2024 Q3	$364K	Hold	20,000	–	–	﹤0.01%	1071
2024 Q2	$364K	Hold	20,000	–	–	﹤0.01%	1062
2024 Q1	$364K	Hold	20,000	–	–	﹤0.01%	1058
2023 Q4	$393K	Hold	20,000	–	–	﹤0.01%	1091
2023 Q3	$361K	Hold	20,000	–	–	﹤0.01%	1089
2023 Q2	$394K	Hold	20,000	–	–	﹤0.01%	1074
2023 Q1	$349K	Hold	20,000	–	–	﹤0.01%	1088
2022 Q4	$405K	Sell	20,000 -23,000	-53%	-$633K	﹤0.01%	1082
2022 Q3	$1.11M	Hold	43,000	–	–	﹤0.01%	850
2022 Q2	$1.05M	Hold	43,000	–	–	﹤0.01%	864
2022 Q1	$1.44M	Buy	43,000 +3,900	+10%	+$131K	﹤0.01%	832
2021 Q4	$1.65M	Buy	39,100 +1,100	+3%	+$42.7K	﹤0.01%	817
2021 Q3	$1.31M	Buy	+38,000	New	+$1.18M	﹤0.01%	837

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

DekaBank Deutsche Girozentrale's RCUS Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 20,000 shares — an estimated $396K sold.

DekaBank Deutsche Girozentrale first reported a position in RCUS in Q3 2021 and held it in 18 quarters. The position peaked at $1.65M in Q4 2021. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 20,000 Arcus Biosciences shares in Q1 2026, an estimated $396K.
DekaBank Deutsche Girozentrale first reported a position in Arcus Biosciences in Q3 2021 and held it in 18 quarters.
DekaBank Deutsche Girozentrale's Arcus Biosciences position peaked at $1.65M in Q4 2021.
210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.